로그인 회원가입
icon_bulk_order대량 주문 Acrobiosystems for English
Recombinant Proteins ClearClear history
Recombinant Proteins CloseClose
Browse Products By Molecule Name a-zA-Z
TL1A Hot |GMP IL-2 Hot |Claudin 18.2 Hot |FMC 63 Ab  |FcRn
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: 홈 > News
뉴스
인사이트
전시회
프로모션
ACROBiosystems launches the world’s first GMP-grade DLL-4 Protein
ACROBiosystems, a global cornerstone of the pharmaceutical industry committed to offering innovative tools and solutions, announces the launch of GMP grade DLL4. GMP grade DLL4 is the first recombinant Delta-like Ligand 4, or DLL4, to be launched on the market under GMP conditions.
2023/11/09     Read: 344
ACROBiosystems Aneuro Partners with Diagnostic Biochips to Accelerate Neuroscience Drug Discovery
ACROBiosystems Aneuro Partners with Diagnostic Biochips to Accelerate Neuroscience Drug Discovery
2023/06/14     Read: 2449
ACROBiosystems expands custom GMP-grade protein services to drive CGT development and commercialization
ACROBiosystems expands custom GMP-grade protein services to drive CGT development and commercialization
2023/06/08     Read: 1318
Empowering Innovation to the Global Market with Acro Certify
Empowering Innovation to the Global Market with Acro Certify
2023/05/06     Read: 973
ACROBiosystems Launches a new Logistics Center in Switzerland
ACROBiosystems launches its first European logistics center and warehouse in Basel, Switzerland.
2022/11/16     Read: 3887
ComboX™ -- A Combination of Universal Solutions
ComboX™ is a combination of universal solutions targeted for biopharmaceutical drug research, development, and manufacturing. To accelerate and support your research efforts, we aim to provide high-quality and high-performance products whenever and wherever you need them. ComboX™ is a toolbox of ess
2022/09/27     Read: 3281
ACROBiosystems’ new strategic focus – streamlining the transition from preclinical development to commercialization
ACROBiosystems’ new strategic focus – streamlining the transition from preclinical development to commercialization
2023/05/06     Read: 1290
ViruStop, ACROBiosystems’s new brand accelerating the process of vaccine development and approval
Bringing together core R&D tools for rabies, influenza, shingles, Ebola, Zika and other viruses, providing high quality antigens, antibodies, ELISA kits, etc., ACROBiosystems is willing to work together with biopharmaceutical companies, blocking the spread of viruses, Stop Viruses!
2022/06/22     Read: 4244
ACROBiosystems was titled 2022 CiteAb Awards protein supplier winner, gaining global scientific approval
Recently, ACROBiosystems won Cite Awards, being titled "the Winner of Protein Supplier to Watch in 2022".
2022/03/29     Read: 46415
Notification Letter
2021/11/12     Read: 2545
더.

This web search service is supported by Google Inc.

totop
Call us
우리에게 전화하세요
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521
Email
이메일
order.kr@acrobiosystems.com
Fax
팩시
+1 888-377-6111
Address
주소
1 Innovation Way, Newark, DE 19711, USA
linkedin twitter facebook youtube

대글

Copyright © 2017 ACROBiosystems. All Rights Reserved
Related Links|Privacy Policy|Terms and Conditions|Legal|Sitemap